C

Cyclerion Therapeutics
D

CYCN

2.80000
USD
-0.18
(-6.04%)
مفتوح الان
حجم التداول
287
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
9,970,638
أصول ذات صلة
ALNY
ALNY
0.36
(0.11%)
329.37 USD
AMGN
AMGN
-3.01
(-0.98%)
303.69 USD
A
ARWR
0.520
(3.30%)
16.260 USD
BMY
BMY
-0.510
(-1.05%)
47.945 USD
GSK
GSK
-0.285
(-0.75%)
37.680 USD
LLY
LLY
1.82
(0.22%)
814.61 USD
MRK
MRK
0.050
(0.06%)
84.830 USD
NVS
NVS
-1.130
(-0.96%)
116.520 USD
PFE
PFE
-0.255
(-1.03%)
24.555 USD
R
RCKT
0.02000
(0.64%)
3.16000 USD
المزيد
الأخبار المقالات

العنوان: Cyclerion Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.